fluvastatin sodium

DRUG2 trials

Sponsors

University of California, San Francisco, Novartis Pharmaceuticals

Conditions

Breast CancerLipid Metabolism Disorders

Phase 2

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

CompletedNCT00416403

University of California, San FranciscoBreast Cancer

Start: 2006-07-31End: 2011-06-30Updated: 2012-12-13

Phase 4

Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

CompletedNCT01551173

Novartis PharmaceuticalsLipid Metabolism Disorders

Start: 2012-01-31End: 2013-05-31Updated: 2015-08-13